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Abstract—We have developed poly(L-lactide-co-glycolide)
(PLGA) based composites using sol–gel derived bioactive
glasses (S-BG), previously described by our group, as
composite components. Two different composite types were
manufactured that contained either S2—high content silica
S-BG, or A2—high content lime S-BG. The composites were
evaluated in the form of sheets and 3D scaffolds. Sheets
containing 12, 21, and 33 vol.% of each bioactive glass were
characterized for mechanical properties, wettability, hydro-
lytic degradation, and surface bioactivity. Sheets containing
A2 S-BG rapidly formed a hydroxyapatite surface layer after
incubation in simulated body ﬂuid. The incorporation of
either S-BG increased the tensile strength and Young’s
modulus of the composites and tailored their degradation
rates compared to starting compounds. Sheets and 3D
scaffolds were evaluated for their ability to support growth
of human bone marrow cells (BMC) and MG-63 cells,
respectively. Cells were grown in non-differentiating, osteo-
genic or osteoclast-inducing conditions. Osteogenesis was
induced with either recombinant human BMP-2 or dexa-
methasone, and osteoclast formation with M-CSF. BMC
viability was lower at higher S-BG content, though speciﬁc
ALP/cell was signiﬁcantly higher on PLGA/A2-33 compos-
ites. Composites containing S2 S-BG enhanced calciﬁcation
of extracellular matrix by BMC, whereas incorporation of
A2 S-BG in the composites promoted osteoclast formation
from BMC. MG-63 osteoblast-like cells seeded in porous
scaffolds containing S2 maintained viability and secreted
collagen and calcium throughout the scaffolds. Overall, the
presented data show functional versatility of the composites
studied and indicate their potential to design a wide variety
of implant materials differing in physico-chemical properties
and biological applications. We propose these sol–gel derived
bioactive glass–PLGA composites may prove excellent
potential orthopedic and dental biomaterials supporting
bone formation and remodeling.
Keywords—Bioactive glass, Sol–gel method, Poly(L-lactide-
co-glycolide), Bioactive composites, Bone morphogenetic
proteins, Human bone marrow cells, MG-63 cells, Alkaline
phosphatase, Mineralization, Osteoclasts.
INTRODUCTION
Current treatments of bone defects include the use
of autografts, allografts, and artiﬁcial biomaterials.
2
The availability of auto- and allografts continues to
be limited by supply, donor-site morbidity, the risk of
immune rejection and infections and, often, high
costs.
15 Orthopedic implants made of artiﬁcial mate-
rials offer an alternative to supply the growing needs
for bone replacement therapies. Beyond the widely
recognized titanium implants, the latter can be made
of bioresorbable polymers (e.g., polylactides, poly-
glycolide, and their copolymers) and/or bioactive
ceramics (e.g., hydroxyapatite, tricalcium phosphate,
bioactive glasses, glass ceramics). Poly(L-lactide-
co-glycolide) (PLGA) is among the few synthetic
polymers approved for human clinical use because of
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2114good biocompatibility, controllable degradability,
and relatively good processability. PLGA has been
used as scaffolds for bone tissue engineering
32 and
for drug delivery purposes, including delivery of
growth factors and hormones involved in bone
regeneration.
34 However, the polymer itself is bioin-
ert and does not elicit a biological response in bone
cells.
23 Bioactive materials such as bioactive glass, on
the other hand, promote attachment, growth, and
osteogenic differentiation of progenitor cells in vitro
and are capable of forming interfacial bonds with
bone tissue in vivo.
13
Combining polymers and bioactive glass into com-
posites is a relatively new concept in bone tissue
engineering and the beneﬁts of such composites
include: (1) enhanced mechanical properties enabling
better integration with bone tissue,
26 (2) enhanced
bioactivity promoting new bone formation,
4 and (3)
tailored degradation rates allowing the body’s own
bone to heal, grow, remodel, and eventually replace the
graft materials.
25 Speciﬁcally, incorporation of bioac-
tive glass into a polymer base has been shown to delay
the degradation rate of the polymer compared to the
neat polymer foam,
25 enhance the composite’s bioac-
tivity,
4 improve the processing of porous poly(L-lac-
tide)/bioactive glass composites
44 and improve the
mechanical properties of these composites.
26,28 Several
approaches employed biodegradable polymers and
the melt-derived 45S5 Bioglass
  developed by
Hench
8,22,39,42,43 but very few reports applied sol–gel
derived bioactive glass instead.
24 In general, gel-der-
ived bioactive glasses have a larger surface area and
OH groups are present in their structure. Thus, their
bioactivity is usually higher than bioactive glasses
prepared by melting. Consequently, they may stimu-
late faster regeneration in living bone. Our earlier
studies reported the production, physico-chemical, and
biological properties of gel-derived bioactive glasses of
the CaO–P2O5–SiO2 system.
19,27 We showed that
CaO:SiO2 ratio in these glasses inﬂuenced their physi-
cal and chemical properties and affected the growth
and differentiation of bone marrow-derived cells.
6,17,20
Our data further indicate that incorporation of these
gel-derived glasses into a HA matrix enhanced growth
and osteogenic differentiation of human mesenchymal
stem cells (MSC).
5 Recently, Wu et al.
41 suggested that
PLGA-based composites prepared with a sol–gel
derived mesoporous bioactive glass possess advanta-
geous mechanical and biological properties compared
to those containing non-mesoporous bioactive glass.
Mesoporous, gel-derived bioactive glasses (MBG) have
a highly ordered structure and generally higher bio-
activity than non-mesoporous bioactive glass obtained
by melting. MBG/PLGA ﬁlms have been characterized
by excellent physicochemical, biological, and drug
release properties and have been processed into 3D
scaffolds suitable for bone tissue engineering.
41
In this work we have employed either silica-rich (S2)
or calcium-rich (A2) bioactive glasses derived from
a basic CaO–P2O5–SiO2 system and obtained by a
sol–gel method, to prepare PLGA-based composites.
These composites were prepared in the form of sheets
and 3D scaffolds and evaluated for their mechanical
properties, bioactivity and the ability to enhance BMP-
2 mediated human bone marrow cell osteogenesis,
support osteoclast formation from human bone mar-
row and osteogenic gene expression of MG-63 osteo-
blastic cells.
MATERIALS AND METHODS
Materials
PLGA was synthesized via a ring opening process in
the presence of low toxicity zirconium acetylacetonate
as a copolymerization initiator.
11 The molar ratio of
L-lactide to glycolide in the copolymer was 85:15
(as studied by
1H NMR), and molecular masses of
PLGA were: Mn = 80 kDa and Mw = 152 kDa. Bio-
active glasses (S2 and A2) of the composition of: S2:
80 mol% SiO2–16 mol% CaO–4 mol% P2O5, and A2:
40 mol% SiO2–54 mol% CaO–6 mol% P2O5, were
produced using the sol–gel method.
19 Tetraeth-
oxysilane (TEOS; Si(OC2H5)4), triethylphosphate
(TEP; OP(OC2H5)3), and calcium nitrate tetra-hydrate
(Ca(NO3)2Æ4H2O) were used as base components to
start the sol–gel process. HCl solution was used as a
catalyst for the hydrolysis and condensation reactions.
The formed gel was dried at 40–120  C for 7 days and
then subjected to thermal treatment at 700  C for 20 h.
Afterwards it was milled to obtain a bioactive glass
powder with particle sizes <50 lm.
Composite Sheets Fabrication
The PLGA–bioactive glass composites were fabri-
cated by mixing glass particles with 10% w/v PLGA
solution in methylene chloride on a magnetic stirrer for
3 h, followed by partial evaporation of the solvent in
air, slip casting of the viscous mixture on glass Petri
dishes, then drying in air and vacuum to a constant
weight. The volume fraction of bioactive glass in the
composites was 12, 21, and 33%. The composite sheets
obtained were 0.11 mm thick.
Composite Scaﬀolds Fabrication
3D scaﬀolds were obtained by addition of
sodium chloride (grain fraction 320–400 lm) into the
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ride. The amount of sodium chloride provided 85%
porosity. NaCl particles were mixed with the PLGA–S-
BG suspension with the use of spatula until most of the
methylene chloride had evaporated. The dense sus-
pension was tightly packed into polypropylene cylin-
drical vials (12 mm in diameter, volume 5 mL), dried
in air for 24 h and then in vacuum conditions for 48 h.
Then the vials with the rigid salt/PLGA–S-BG mixture
were cut into slices of the thickness of 3 mm and
extensively washed in ultra-high quality water (UHQ-
water, produced by UHQ-PS puriﬁcation system, Elga,
UK). The water was exchanged several times until the
conductivity of the water was about 2 lS/cm. Subse-
quently the samples were air-dried and then vacuum-
dried for at least 24 h.
Material Evaluation
The mechanical properties of the sheets, i.e., tensile
strength, Young’s modulus, and elongation at break of
the PLGA–bioactive glass composites were determined
with the use of an universal testing machine (Zwick
1435, Germany) and compared to pure PLGA sheets.
The parallel specimen length was set to 40 mm, the
specimen width was 5 mm, the pre-load force was
0.1 N, the test speed was 100 mm/min and six samples
were evaluated from each experimental group.
Wettability was evaluated by water contact angle
measurements. The contact angle was determined by
sessile drop method by an automatic drop shape
analysis system DSA 10 Mk2 (Kruss, Germany).
UHQ-water droplets of 0.2 lL were applied on each
sample and the contact angle was calculated by aver-
aging 10 measurements.
To study hydrolytic degradation, the composites,
and reference samples (PLGA, S2, and A2) weighing
0.15 g were placed in separate plastic vials and incu-
bated in 30 mL UHQ-water at 37  C for 3 months.
The evaluation was performed according to interna-
tional standard (ISO 10993-13).
16 Hydrolytic degra-
dation process was monitored by pH and conductivity
measurements of incubation medium with the use of
pH meter (CP-315 Elmetron, Poland) and conduc-
tometer (CC-315, Elmetron, Poland), respectively.
The arithmetical mean roughness (Ra) and ten-
point mean roughness depth (Rz) of a surface were
determined. These parameters were quantiﬁed using a
proﬁlometer (TR-100 Surface Roughness Tester).
Bioactivity of the composites was assessed by an
in vitro simulated body ﬂuid (SBF) test according to
the method described in the work of Niemiel et al.
28 In
brief, SBF was prepared by dissolving the following
chemicals (POCh, Gliwice, Poland) in UHQ-water:
141 mM NaCl, 4 mM KCl, 0.5 mM MgSO4,1m M
MgCl2, 4.2 mM NaHCO3, 2.5 mM CaCl2, and
1.0 mM KH2PO4. The resulting SBF was buffered to
pH 7.28 with Tris(hydroxymethyl aminomethane)/
HCl. The sheets weighing 1 g were immersed in
100 mL of SBF solution and incubated at 37  C for
10 days. The SBF solution was exchanged every 3 days
to ensure sufﬁcient ion concentrations for mineral
growth. Afterwards the samples were washed in UHQ-
water, air- and vacuum-dried to a constant weight.
Microstructure and chemical composition of PLGA
and composite sheets before and after soaking in SBF
were examined by SEM/EDAX analysis (NanoSEM,
FEI, USA, accelerating voltage 10 and 18 kV, magni-
ﬁcations 5009 and 5,0009). The EDAX spectra were
averaged for the whole analyzed surface at the mag-
niﬁcation of 5,0009.
Material Sterilization
For cell culture, composite sheets (round samples
matching the size of culture vessels) were sterilized by
soaking in 70% ethanol for 30 min, washed with
phosphate buﬀered saline (PBS) and further sterilized
by UV light for 15 min. 3D scaﬀolds were sterilized in
70% ethanol for 72 h, washed in PBS and air-dried
before cell seeding.
Cell Cultures
Evaluation of 2D Sheets
Adult human bone marrow cells (BMC) were har-
vested from iliac crest of 10 adult patients (age 19–71,
both genders) under Institutional Review Board-
approved protocol (KBET/17/L/2007). The mononu-
clear fraction, which contains both mesenchymal and
hematopoetic cells, was isolated as described previ-
ously.
30Cellswereeitherexpandedinprimarycultureto
selectforMSCortheyweredirectlyseededonthesheets
(BMC mononuclear fraction). For selection of MSC,
primaryBMCwereculturedintissuecultureﬂasksusing
alpha-MEM supplemented with 10% pre-selected
MSC-qualiﬁed fetal bovine serum (MSC-FBS) and 1%
antibiotics (Penicillin/Streptomycin; Invitrogen). Med-
ium was changed twice weekly until a conﬂuent cell
monolayer was developed. Cells were then detached
from culture ﬂasks using 0.25% Trypsin–EDTA
(Invitrogen) and seeded onto the composite sheets or
further expanded. To induce alkaline phosphatase
(ALP) activity, the early marker of osteogenesis, MSC
were seeded on composite sheets (round samples of
15 mm in diameter) at a density of 10
4 cells/cm
2 and
culturedineitheralpha-MEM/MSC-FBS/antibioticsor
supplemented with 100 lg/mL ascorbate-2-phosphate
(ascorbate; Sigma) and 100 ng/mL recombinant human
BMP-2 (BMP-2; R&D Systems). Gene expression of
PAMULA et al. 2116osteogenic markers was analyzed in parallel cultures
established on composite sheets of higher surface area
(round samples of 28 mm in diameter) and treated with
ascorbate and BMP-2. For calcium deposition, cultures
were supplemented with 100 lg/mL ascorbate, 10 mM
b-glycerophosphate (Sigma), 100 ng/mL BMP-2 or
10
27 M dexamethasone (Sigma). Analyzes were per-
formed after 1 week (MTS, ALP, gene expression
studies)or3 weeks(calciﬁcationofextracellularmatrix)
of culture. Osteoclast formation was induced using
BMC mononuclear fraction. After fractionation of
whole bone marrow sample over Ficol gradient a
mononuclear fraction of BMC was isolated and washed
insterilePBStogetridofFicolresidues.
30Mononuclear
cellswereseededonPLGAandcompositesheets(round
samples of 28 mm in diameter) at a density of
4.7 9 10
6 cell/well/6-well plates in alpha-MEM/MSC-
FBS/antibiotics and supplemented with 100 ng/mL
human recombinant macrophage colony stimulating
factor (M-CSF, Peprotech). After 3 days of culture,
medium, and ﬂoating cells were collected, transferred to
corresponding standard tissue culture 6-well plates and
further cultured in standard alpha-MEM/MSC-FBS/
antibiotics for a total of 23 culture days. Medium was
changed every 3 days starting from culture day 8.
Evaluation of 3D Scaﬀolds
MG-63 cells (human bone osteosarcoma-derived
cells; Lonza USA) were expanded using DMEM High
Glucose (Biosera, UK) supplemented with 10% FBS
(PAA), 1% antibiotics, and 0.25% fungizone (Sigma).
For experiments with 3D composites and control
PLGA 3D scaﬀolds MG-63 cells were suspended at a
density of 2 9 10
5 cells/150 lL of PBS containing
1.75 mg/mL of ﬁbrinogen (Sigma). To induce clot
formation, cell suspension was supplemented with
thrombin (1 unit/mL). Each 3D scaffold (12 mm in
diameter, 2 mm thickness) was placed in a separate
well of 6-well plate and held by stainless steel ring to
facilitate cell loading. Aliquots of 150 lL cell suspen-
sions were loaded into the scaffolds and incubated for
40 min at 37  C in a humidiﬁed, 5% CO2 atmosphere,
followed by addition of standard DMEM/FBS/anti-
biotics. After 24 h of initial culture, the steel ring was
removed and medium was supplemented with 50 lg/
mL ascorbate-2-phosphate, 10
27 M dexamethasone,
and 5 mM b-glycerophosphate (Sigma). Media and
supplements were changed every 2–3 days and ana-
lyzes done after 2 weeks of culture.
2D Culture Analyzes
Seven-day osteogenic cultures were analyzed for
cell metabolic activity using CellTiter96AQueous One
Solution Cell Proliferation Assay (MTS, Promega), a
tetrazolium salt assay. Cell numbers of human MSC or
MG-63 cells were estimated based on standard curves
established with cells cultured at diﬀerent densities and
A490nm MTS values that were measured at appropriate
time intervals. The linear regressions between cell
numbers and A490nm MTS values were evaluated and
the linear regression equations from the data ﬁtting
were used to determine the experimental cell numbers.
ALP activity was assayed as described previously,
37
and the results were normalized to live cell number to
obtain speciﬁc ALP activity/cell values. We have
previously determined that, using our hMSC culture
regimens, ALP peaks at day 7 and reaches plateau by
day 10,
9,10,29,30 and day 7 culture time point was pre-
viously used to analyze cellular ALP activity on dif-
ferent bioglass surfaces.
17 Analyzes of gene expression
levels in osteogenic cultures were performed after 7-
day cultures on selected composite sheets and PLGA,
and compared to gene expression levels in cells cul-
tured on standard tissue culture plastic (TCP). Brieﬂy:
2 lg of total RNA from each culture (NucleoSpin
 
RNA II, MACHEREY–NAGEL) were reverse-tran-
scribed to cDNA (SuperScript III First Strand Syn-
thesis System, Invitrogen) and used for the analyzes of
gene expression levels in StepOnePlus Real-Time PCR
apparatus (Applied Biosystems). Samples of cDNA
were diluted 109 and 2-lL aliquots of diluted cDNA
were used for PCR reactions. Each reaction mixture
(15 lL total volume) contained cDNA, gene-speciﬁc
primers, SYBR
  Green I, AmpliTaq Gold
  DNA Poly-
merase and the reaction buffer as recommended by the
manufacturer (SYBR
  Green PCR MasterMix, Applied
Biosystems). The following primers were used for
the PCR analyzes: TATA (house keeping gene) for-
ward 5¢-GGAGCTGTGATGTGAAGTTTACTA-3¢,
reverse 5¢-CCAGGAAATAACTCTGGCTCATAA
C-3¢; BMP-2 forward 5¢-TGCTAGTAACTTTTGGC
ATGATG-3¢; reverse 5¢-GCGTTTCCGCTGTTTGT
GTT-3¢; MSX-2 forward 5¢-GCACCCTGAGGAAA
CACAAG-3¢, reverse 5¢-GGTGGTCGCTTCGGTA
AA-3¢; osterix (OSX) forward 5¢-ACTCACACCCGG
GAGAAGAA-3¢, reverse 5¢-GGTGGTCGCTTCGG
GTAAA-3¢; osteopontin (OPN) forward 5¢-TGGAA
AGCGAGGAGTTGAATG-3¢, reverse 5¢-CATCCA
GCTGACTCGTTTCATAA-3¢, bone sialoprotein
(BSP) forward: 5¢-AATGAAAACGAAGAAAGCG
AAG-3¢, reverse 5¢-ATCATAGCCATCGTAGCCTT
GT-3¢, osteocalcin (OC) forward 5¢-AAGAGACCCA
GGCGCTACCT-3¢, reverse 5¢-AACTCGTCACAGT
CCGGATTG-3¢. The PCR reactions were performed
for 40 cycles with denaturation step at 95  C for 30 s,
annealing at 60  C for 1 min, and elongation at 72  C
for 30 s. Relative quantiﬁcation (ddCT method) was
used to analyze the results. Osteoclast formation was
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inverted contrast-phase microscope (Axiovert 40, Carl
Zeiss). At the end of culture, pre-osteoclasts and
osteoclasts were stained for tartrate-resistance acid
phosphatase, as previously described.
20
3D Culture Analyzes
3D cultures were analyzed at day 14 for live cell
number by MTS, collagen production and calciﬁcation
of extracellular matrix. After MTS assay the scaﬀolds
were washed with PBS, ﬁxed with 0.5 mL of 8% for-
malin solution and cut in halves to facilitate the
staining and destaining procedures. For collagen
detection, 1 mL of Sirus Red (Sigma) was added per
scaﬀold and staining was performed for 18 h at room
temperature with gentle rocking. Afterwards, the stain
was removed, scaﬀolds extensively washed with
deionized water and destained for few minutes using
0.5 mL of a solution containing equal volumes of
0.2 M sodium hydroxide and methanol. For calciﬁca-
tion of extracellular matrix, 1 mL of 0.1% Alizarin
Red S water solution was added per scaﬀold and
staining was performed at room temperature for
40 min with vigorous shaking. Destaining was per-
formed for 10 min using 0.5 mL of 5% perchloric acid
water solution per scaﬀold and gentle rocking.
Recovered stains were then transferred to a clear
96-well plate in 200-lL aliquots and the absorbance
was read at 490 nm using a plate reader. Collagen and
calciﬁcation results were normalized to live cell number
to obtain speciﬁc collagen/cell and mineral/cell values.
For the analyzes of cell distribution with the confocal
microscope, the scaffolds were ﬁxed in 8% formalin
solution at room temperature for 20 min. Then the
scaffolds were washed three times with PBS. Actin
cytoskeleton of the cells was visualized with phalloidin-
TRITC solution (Molecular Probes, Invitrogen) in
PBS (1:2000 dilution of the original stock). 1 mL of
staining solution was added to each scaffold for
40 min. Then the scaffolds were washed three times
with PBS followed by nuclei staining with DAPI in
PBS (1 mL DAPI/scaffold; 1:1000 dilution of original
DAPI stock) for 30 min. The confocal images were
taken as 12-bit z-stack with LSM 510 Meta microscope
using 409 magniﬁcation of achroplan objective.
Statistical Analysis
Multi-way ANOVA was used for statistical analyzes
of mechanical properties and contact angle values.
Biological evaluations were done with at least three
separate cultures and data from each culture were
usually collected in triplicates. Because the number of
biological samples from each studied group was less
than 10, data were analyzed by nonparametric
Kruskal–Wallis test, followed by Tukey post hoc test:
p<0.05 was considered signiﬁcant.
RESULTS
Mechanical Properties and Water Contact Angle
The mechanical properties of PLGA and PLGA/
S-BG composites are given in Figs. 1a–1c. Tensile
strength (Rm) was comparable for pure PLGA and
composites containing either 21%S2 or 21%A2 S-BG.
Low S-BG contents (12%) in the composites
enhanced, and high (33%) reduced tensile strength
(Fig. 1a). All composites, except for PLGA/A2-33 had
signiﬁcantly higher Young’s modulus (Fig. 1b) and
all exhibited signiﬁcantly lower elongation at break
(Fig. 1c) compared to pure PLGA (Figs. 1b, 1c).
Contact angle values for PLGA/A2 composites were
signiﬁcantly lower than for PLGA/S2 composites
(Fig. 1d). Contact angle values for the latter were
comparable to pure PLGA. Surface roughness param-
eters, i.e., the arithmetical mean roughness (Ra)
and ten-point mean roughness depth (Rz) (Table 1)
increased with increased S-BG content in the com-
posites. Ra values for composites containing 33% of
either S-BG were comparable to values obtained for
pure PLGA. In contrast, Rz values for composites
containing either S-BG were approximately 5–13 fold
higher compared to Rz of pure PLGA, depending on
S-BG content.
Degradation Rate
Degradation rates of the samples were evaluated
based on pH and conductivity measurements of the
incubation medium (Fig. 2) and compared to degra-
dation rates of pure PLGA and pure bioactive glasses
S2 or A2. Materials in the form of sheets were soaked
in UHQ-water for 3 months. Pure PLGA did not
inﬂuence pH and conductivity of the incubation med-
ium up to the tenth week of incubation; this was fol-
lowed by a rapid decrease of pH and increase of
conductivity of the incubation medium. In contrast,
the pH of the composites’ incubation media stabi-
lized at neutral level by second week and remained
unchanged until the end of experiments (Figs. 2a, 2c).
Notably, PLGA/A2 composites containing either 21%
or 33% A2 alkalized the incubation media during
initial 2-week incubation period (Fig. 2c) and the
conductivities of these incubation media were mark-
edly increased compared to other materials studied
(Fig. 2d). For PLGA/S2 bioactive glass, conductivities
of their incubation media increased slightly within the
PAMULA et al. 2118ﬁrst week, and remained unchanged till the end of the
experiment (Fig. 2b). Notably, the conductivity values
obtained for PLGA/S2 incubation media did not reach
the values comparable to those obtained for PLGA/A2
composites throughout the entire incubation period.
Figures 3a, 3b show that bioactive glass particles
were evenly distributed on the surface of both PLGA/
S2-21 and PLGA/A2-21 composites. After 3-month
incubation in UHQ-water the preferential erosion of
the polymer at the interface PLGA base/bioglass par-
ticles was visible (Figs. 3c, 3d). As a result some of the
bioglass particles were exposed and were able to release
ions affecting pH and conductivity of incubation
medium (Fig. 2).
Evaluation of Bioactivity
The formation of an apatite-like layer on the
material surface as a result of soaking in SBF is a
commonly used method to determine bioactive
properties of materials. The results of SEM and
EDAX analyzes for representative samples are shown
in Figs. 4a–4f. We did not observe any signiﬁcant
changes in surface morphology or chemical compo-
sition of pure PLGA sheets after soaking in SBF
(Figs. 4a, 4b). The surfaces of PLGA–bioactive glass
composites were smooth with uniformly distributed
glass particles before the incubation in SBF (Figs. 4c,
4e). Oxygen and carbon originating from PLGA, and
small amounts of calcium and silicon originating from
bioactive glass were detected by EDAX (Figs. 4c, 4e,
insets). After incubation in SBF, PLGA/S2 bioactive
glass composites displayed limited surface changes,
though mineral deposits containing calcium and
phosphorus were formed as detected by EDAX
(Fig. 4d). On the contrary, distinct changes in surface
morphology were observed for the PLGA/A2 bioac-
tive glass composites (Fig. 4f). The latter was covered
with spherical calcium phosphate nodules of cauli-
ﬂower-like morphology, typical of hydroxyapatite
precipitated from SBF.
12,18,36 FTIR-ATR analysis,
performed according to the method described previ-
ously,
12 conﬁrmed that low-crystalline hydroxyapatite
was created on the surface of PLGA/A2-21, but not
on the surface of PLGA/S2-21 (data not shown).
These results indicate that incorporation of bioactive
glass particles into PLGA enhanced formation of
apatite-like bioactive layer on the composite surfaces,
though this was dependent on the chemical compo-
sition of incorporated bioactive glass. Addition of
bioactive glass of high CaO concentration (A2)
resulted in faster apatite-like layer formation. It seems
this bioactive glass is a more effective source of Ca
than S2 bioactive glass. Consequently, supersatura-
tion of SBF solution in relation to apatite is faster in
the presence of PLGA/A2 S-BG composites than
PLGA/S2 S-BG containing ones.
FIGURE 1. Tensile strength Rm (a), Young’s modulus (b),
elongation at break e (c), and contact angle values (d) of PLGA
and PLGA/S-BG composites. Results are expressed as
mean 6 S.E. Statistically signiﬁcant differences (p<0.05)
from PLGA are indicated by letter code a. Statistically signif-
icant differences between other groups are indicated by
connectors and asterisk.
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Evaluation of 2D Cultures
Cell numbers were estimated based on MTS stan-
dard curve for human MSC cultures that were seeded
at diﬀerent densities and culture media were assayed
for A490nm changes at appropriate time intervals. Cell
numbers of human MSC cultured for 7 days on
PLGA/S2-12 and PLGA/S2-21 composite sheets in
standard medium were comparable to cultures on pure
PLGA and signiﬁcantly higher than on TCP (Fig. 5a).
The number of cells grown on other composite sheets
was not different from those on TCP.
Human MSC cell numbers decreased with increased
bioactive glass content as a result of culturing hMSC
on composite sheets in osteogenic medium containing
bone morphogenetic protein 2 (BMP-2) (Fig. 5b).
We have previously indicated BMP-2 to be a week
inducer of osteogenesis in human compared to rodent
MSC cultures
29 and also a poor osteogenic inducer
in standard serum-containing human MSC cultures
compared to dexamethasone.
9,10 Thus, it was of
interest to test the BMP response of human MSC on
bioactive composite sheets. We determined that spe-
ciﬁc ALP activity (i.e., ALP/cell) signiﬁcantly increased
for PLGA/A2 composites compared to TCP and the
increases were proportional to the bioactive glass
content (Fig. 5c). Pure PLGA sheets provided similar
results. Speciﬁc ALP activity for PLGA/S2-33 sheets
was higher than PLGA/S2-12 and PLGA/S2-21,
but the results were not statistically signiﬁcant and
none was signiﬁcantly different from the speciﬁc ALP
activity of cells grown on TCP. Real-time PCR ana-
lyzes of gene expression levels that are characteristic
for cells undergoing osteogenic differentiation were
performed after 7-day hMSC culture on PLGA and
composite sheets containing either 21%S2 or 21%A2
S-BG, and results referred to gene expression levels for
cells cultured on TCP (Fig. 6). The selection of com-
posites for gene expression studies was based on
TABLE 1. Surface roughness parameters (Ra, Rz) of PLGA and PLGA/S-BG composites (mean 6 S.D.).
PLGA PLGA/S2-12 PLGA/S2-21 PLGA/S2-33 PLGA/A2-12 PLGA/A2-21 PLGA/A2-33
Ra (lm) 1.54 ± 0.28 0.59 ± 0.08 0.8 ± 0.1 1.5 ± 1.5 0.75 ± 0.07 1.6 ± 0.1 1.7 ± 0.1
Rz (lm) 1.15 ± 0.81 5.30 ± 0.68 7.4 ± 1.0 13.7 ± 1.6 6.7 ± 1.1 11.8 ± 1.4 12.7 ± 1.1
FIGURE 2. UHQ-water pH (a, c) and conductivity (b, d) changes during 3-month incubation of PLGA/S-BG composite samples and
starting compounds (PLGA and bioactive glass S2 or A2).
PAMULA et al. 2120moderate mechanical and biological properties of these
sheets. The analyzed transcripts included BMP-2
mRNA, since BMP-2 can regulate its own expres-
sion, and MSX-2 and OSTERIX that are tran-
scription factors expressed early during osteogenesis
and regulated by BMP-2.
21 In addition, we ana-
lyzed OSTEOPONTIN, BONE SIALOPROTEIN and
OSTEOCALCIN that are synthesized by osteoblasts
and deposited in bone matrix. The results showed
comparable expression levels for most selected genes
on all studied surfaces (Figs. 6a–6f) suggesting that
osteogenic differentiation of hMSC by day 7 cultures
was not signiﬁcantly affected by the composite surface
properties and/or their dissolution products. It should
be noted, however, that hMSC grown on composite
sheets expressed signiﬁcantly higher levels of BMP-2
(PLGA/A2-21 vs. PLGA/S2-21; PLGA/A2-21 vs.
TCP; Fig. 6a) and OSTEOPONTIN (OPN) mRNA
(PLGA/S2-21 and PLGA/A2-21 vs. TCP; PLGA/S2-
21 vs. PLGA/A2-21; Fig. 5d) and signiﬁcantly lower
levels of MSX-2 mRNA (PLGA/A2-21 vs. TCP;
Fig. 5b).
Human MSC grown for 3 weeks on TCP in BMP-2
containing osteogenic conditions stained mildly for
Alizarin Red S, but staining was clearly visible for
cells for which osteogenesis was induced by dexa-
methasone (data not shown). When hMSC were
grown on PLGA/S-BG composites, strong Alizarin
Red S staining was apparent on all PLGA/S2 and
PLGA/A2-12 composite sheets. Corresponding sheets
incubated in cell-free conditions remained unstained.
Thus, these materials enhanced cell-mediated calciﬁ-
cation of extracellular matrix, and this was the case
for either dexamethasone or BMP-2 treated cells
(Fig. 7). For PLGA/A2-21 and PLGA/A2-33 the
Alizarin red staining intensity was very high without
cells, thus it was difﬁcult to distinguish between
material-induced and cell-induced calciﬁcation. Pure
PLGA sheets remained unstained with or without
cells and regardless of culture treatments.
When primary BMC were pre-treated with M-CSF
for 3 days on PLGA-bioactive glass sheets, followed
by 3-week culture of ﬂoaters on TCP in stan-
dard medium, the morphology of cells that came into
FIGURE 3. SEM pictures of PLGA/S2-21 before (a) and after incubation in UHQ-water for 3 months (c), PLGA/A2-21 before (b) and
after incubation in UHQ-water for 3 months (d); original magniﬁcation 3500.
Degradation, Bioactivity, and Osteogenic Potential of PLGA-S-BG Composites 2121contact with PLGA/A2-21 sheets was distinct from
these pre-cultured on PLGA/S2-21 and pure PLGA
sheets. Round, TRAP-positive and multinucleated
cells could be observed in cultures established from
ﬂoating cells aspirated from PLGA/A2-21 (Figs. 8c,
8d), whereas cells transferred from PLGA/S2-21 and
pure PLGA sheets developed into ﬁbroblast-like cells
negative for TRAP (Figs. 8a, 8b).
Evaluation of 3D Cultures
MG-63 cells loaded into 3D PLGA, PLGA/S2-21,
and PLGA/A2-21 attached to the sides of the scaﬀold
pores and remained viable after 2 weeks of culture, as
determined by phalloidin/DAPI staining (Fig. 9a,
confocal images). Cell numbers were comparable in
all studied scaffolds as determined by MTS assay
FIGURE 4. SEM pictures and EDAX spectra (insets) of: PLGA surface before (a) and after 10-day incubation in SBF (b), PLGA/S2-
21 before (c) and after 10-day incubation in SBF (d), PLGA/A2-21 before (e) and after 10-day incubation in SBF (f); original
magniﬁcation 35,000.
PAMULA et al. 2122described in ‘‘Materials and Methods’’ section
(Fig. 9b). In contrast, the production of collagen/cell
(Fig. 9c) and calcium/cell (Fig. 9d) was signiﬁcantly
increased for cells cultured on composite scaffolds
compared to pure PLGA.
DISCUSSION
We report here that the incorporation of either S2
or A2 sol–gel derived bioactive glass into PLGA results
in composites of enhanced mechanical properties and
tailored degradation rates, but biological activities of
these composites depend both on the content and
composition of the bioactive glass components.
Incorporation of either S2 or A2 S-BG into PLGA
resulted in creation of stiﬀer materials compared to
pure PLGA, as determined by increased Young’s
modulus and lowered elongation at break (Fig. 1).
Tensile strength of the composites depended on the
bioactive glass content and was signiﬁcantly higher for
composites containing 12% of either S-BG compared
to pure PLGA. Notably, tensile strengths of these
composites exceeded 50 MPa (Fig. 1a), a value com-
parable to that of trabecular bone.
7 The increase in
tensile strength and Young’s modulus of PLGA/S-BG
composites suggests that S-BG particles act as a rein-
forcing phase within the polymer matrix. In addition
SEM observations show that the S-BG particles are
uniformly distributed within the PLGA base and do
not form agglomerates (Figs. 3a, 3b). Thus, it is pos-
sible to obtain composites of mechanical properties
similar to those of natural bone simply by adjusting
bioactive glass content. Interestingly, similarly to
recent work of Wu et al.
41 increasing A2 S-BG content
to 33% signiﬁcantly decreased the tensile strength of
the composites compared to pure PLGA; also the
modulus of PLGA/A2-33 was signiﬁcantly decreased
compared to other composites (Fig. 1b). However, our
SEM analyzes of composites containing 33% of either
S-BG indicated bioactive glass grains uniformly
embedded in the polymer matrix with no microcracks
(data not shown).
Both S2 and A2 containing composites displayed
modiﬁed degradation rates compared to pure PLGA,
S2 and A2 S-BG, and neutralized acidic degradation
by-products of pure PLGA at later incubation stages,
as determined by pH and conductivity of incubation
solutions. Notably, higher contents of A2 S-BG in the
composites increased both pH and conductivity of the
environment; the latter was not observed for S2 S-BG
(Fig. 2). PLGA degrades through chain scission of
polyester bonds due to hydrolysis. This results in
oligomers formation leading to ﬁnal degradation
products of glycolic and lactic acids.
33 Thus, at tenth
FIGURE 5. Growth and differentiation of human MSC after
7-day culture on PLGA/S-BG composites, pure PLGA and
tissue culture plastic (TCP). Cell number after culture in
standard conditions without osteogenic inducers (a) and after
stimulation with rhBMP-2 (b). Alkaline phosphatase (ALP)
activity of cells after stimulation with rhBMP-2 (c). Results are
expressed as mean 6 S.E. Statistically signiﬁcant differences
(p<0.05) from a PLGA and b TCP are indicated by letter code,
respectively. Statistically signiﬁcant differences between
other groups are indicated by connectors and asterisk. Cell
numbers were signiﬁcantly higher on composite sheets con-
taining low and mid w/v% of S2 S-BG compared to TCP when
cultured without inducers, and signiﬁcantly lower on com-
posite sheets containing low and high w/v% of A2 S-BG
compared to PLGA (a). When stimulated with rhBMP-2, cell
numbers on composites containing high w/v% S-BG were
signiﬁcantly lower compared to either PLGA or TCP (b). Cells
cultured on PLGA/A2-33 and stimulated with rhBMP-2 dis-
played signiﬁcantly higher ALP activity levels compared to
PLGA and TCP (c). ALP activity levels of cells stimulated with
rhBMP-2 were signiﬁcantly higher on all studied A2 S-BG and
PLGA/S2-33 compared to TCP (c).
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products decreased pH and increased conductivity of
the incubation medium (Fig. 2). Immersion of S-BG in
water provokes the increase of pH and conductivity
due to release of calcium ions from the materials to the
incubation medium, and protons uptake. Although
PLGA/S2 composites did not provoke signiﬁcant
changes in pH and conductivity of the incubation
medium, past the tenth week in water, their degrada-
tion rates remained constant in contrast to pure
PLGA. This may be due to (i) lower degradation of the
PLGA base in the S2 containing composites, or (ii) the
acidic degradation products of PLGA reacting with
alkaline degradation products of S2 bioactive glass.
The former can be ruled out based on reports indi-
cating that the presence of ceramic particles or carbon
ﬁbers in PLGA composites speeds up degradation
3,31
and forms a new interface that improves diffusion of
water molecules into the bulk of the composites. Thus,
it is plausible that the PLGA/S2 composites degrade
faster than pure PLGA, however, due to the buffering
capacity of S2 S-BG, pH and conductivity of the
incubation medium do not change. Compared to
PLGA/S2 composites, the PLGA/A2 composites dis-
played signiﬁcantly higher pH and conductivity values
and this positively correlated with the concentration of
bioactive glass (Figs. 2c, 2d). Notably, after 3 weeks
immersion of PLGA/A2 composites in UHQ-water,
FIGURE 6. Real-time RT-PCR analyzes of gene expression levels in hMSC cultured for 7 days on PLGA, PLGA/S2-21, and PLGA/
A2-21. Cells were stimulated with ascorbate and BMP-2 and RNA harvested and analyzed as described in respective ‘‘Materials and
Methods’’ sections. Fold changes relative to TCP 5 1 are presented (ddCT method). Results are expressed as mean 6 S.E.
Statistically signiﬁcant differences (p<0.05) from a PLGA and b TCP are indicated by letter code, respectively. Statistically
signiﬁcant differences between other groups are indicated by connectors and asterisk. Human MSC cultured on PLGA/A2-21
sheets displayed signiﬁcantly higher levels of BMP-2 and OPN mRNAs and signiﬁcantly lower levels of MSX-2 mRNA.
FIGURE 7. Comparison of Alizarin Red S staining intensities of PLGA/S-BG composite sheets and pure PLGA in cell-free con-
ditions (control) and after osteogenic human MSC cultures induced with dexamethasone (DEX) and BMP-2. PLGA/S2 composite
sheets enhanced cell-mediated calciﬁcation of ECM—these sheets stained strongly for Alizarin Red S only when subjected to
osteogenic culture. Similar results were obtained for either Dex or BMP induced osteogenic cultures.
PAMULA et al. 2124the pH stabilized at the level of 8 (Fig. 2c), whereas
conductivity increased, especially for PLGA/A2-33
composites (Fig. 2d). This may be due to continuous
release of calcium ions from A2 S-BG and local buf-
fering effects of potential PLGA degradation products.
Overall, both the chemical composition of the S-BG
and the amount in the PLGA base contribute to the
degradation rate of the resulting composites. Using the
composites studied here, it is feasible to design a wide
variety of biodegradable materials differing in degra-
dation kinetics.
The cell numbers of bone marrow human MSC
grown in non-diﬀerentiating conditions were signiﬁ-
cantly higher on PLGA/S2 composite sheets compared
to PLGA/A2 (Fig. 5a). The latter was less hydrophobic
(Fig. 1d) and this could have affected attachment and
growth of osteoprogenitor cells. In contrast, when cells
were grown in osteogenic BMP-containing medium,
the number of cells was comparable on either S-BG-
containing composites and decreased with increased
S-BG content (Fig. 5b). This corresponded to increased
surface roughness parameters of the PLGA/S-BG
composites with increased S-BG contents (Table 1).
The effects of surface roughness and topography on
bone cells have been well documented in the litera-
ture,
14,22,40 who reported lower ALP activity of human
osteoblast-like cells with increased bioactive glass
content in PLAGA-55S5 BG composites. We observed
signiﬁcant increases of speciﬁc ALP/cell (Fig. 5c) in
hMSC cultures grown on composites containing the
highest proportion of A2 S-BG. It is plausible that
PLGA/A2-33 composites slowed cell adhesion and/or
proliferation rates, but stimulated osteogenic differen-
tiation instead. Further analyzes of gene expression
levels of hMSC grown on composite sheets of moderate
properties (i.e., PLGA-21% of either A2 or S2 BG)
showed, in most cases, comparable expression of oste-
ogenic markers that was not signiﬁcantly different from
cells cultured on either PLGA or TCP. This indicates
that the studied surfaces support BMP-mediated oste-
ogenic progression of hMSC at least to the same extent
as polymer itself or TCP. However, hMSC grown on
PLGA/A2-21 sheets had signiﬁcantly higher BMP-2
mRNA expression levels compared to TCP suggesting
they may enhance BMP-mediated signaling. In this
respect, it is unclear why MSX-2 expression was
decreased on PLGA/A2-21 sheets. Though, if these
composites stimulated osteogenic differentiation of
hMSC, they might as well induce expression of MSX-2
at earlier culture stages. Further studies are required to
determine molecular mechanisms of BMP signaling on
these composite sheets.
FIGURE 8. Tartrate-resistant acid phosphatase (TRAP) staining of bone marrow mononuclear cells pre-cultured for 3 days on
pure PLGA and PLGA/S-BG composites in the presence of MCS-F, followed by 3-week culture in standard medium on tissue
culture plastic. Cells pre-cultured on pure PLGA (a) and PLGA/S2-21 composites (b) displayed typical ﬁbroblastic morphology and
they were negative for TRAP. Positive TRAP staining and osteoclast-like morphology of cells was observed for cells pre-cultured
on PLGA/A2-21 composites (c, d).
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17 pure A2
S-BG coatings induced moderate osteogenic effects in
human bone marrow-derived MSC cultures, but acted
as a potent inducer of osteoclast formation and sur-
vival. In this work hMSC grown on PLGA/A2-21
sheets expressed signiﬁcantly higher levels of OSTE-
OPONTIN mRNA as compared to PLGA/S2-21 or
TCP. While elevated osteopontin expression is an
early marker of osteoblast differentiation, it is also
required for osteoclast formation.
1,38 Furthermore,
FIGURE 9. Phalloidin/DAPI staining (a) of MG-63 cells cultured in 3D PLGA, PLGA/S2-21, and PLGA/A2-21 scaffolds and stimu-
lated with ascorbate, dexamethasone, and b-glycerophosphate for 2 weeks. Cells were also analyzed for cell number (b), collagen
(c), and calcium (d) levels after 2-week culture. Results for b–d are expressed as mean 6 S.E. Statistically signiﬁcant differences
(p<0.05) from PLGA are indicated by letter code a. Statistically signiﬁcant differences between other groups are indicated by
connectors and asterisk. Comparable cell numbers were detected in all studied 3D scaffolds, but MG-63 cells cultured in PLGA-
S-BG 3D composites produced signiﬁcantly higher levels of collagen and calcium compared to pure PLGA 3D scaffolds.
PAMULA et al. 2126round, TRAP-positive multinucleated cells could be
observed in cultures established from ﬂoating BMC
aspirated after 3-day primary BMC culture from
PLGA/A2-21 composite sheets, whereas cells trans-
ferred from PLGA/S2-21 and pure PLGA sheets
developed into ﬁbroblast-like cells negative for TRAP.
This may be due to high surface reactivity of PLGA/
A2 composite sheets and their high bioactivity as
determined by SBF studies (Fig. 4f) and Alizarin Red
S staining of these sheets in cell-free conditions
(Fig. 7). Crystallization of hydroxyapatite on the
composite surface and/or osteopontin-rich extra-
cellular matrix would attract osteoclast progenitors
similarly to natural bone. Alternatively, PLGA/A2
composite surfaces promoted the attachment of
osteoprogenitors through, i.e., enhanced BMP-2 sig-
naling and these in turn signaled for osteoclast devel-
opment. Regardless of the mechanisms, our present
data support the concept that calcium-rich bioactive
glasses may be a key component of PLGA-based
composites where the requirement is to support bone
remodeling.
An exciting new ﬁnding of this work is the ability of
PLGA/S-BG composites to support BMP-mediated
osteogenesis of bone marrow-derived human MSC in
standard, serum-containing medium. BMP-2 was pre-
viously shown to be ineﬀective at elevating ALP
activity in MSC derived from bone marrow of adult
patients and cultured on TCP in these same culture
conditions.
30 Recent attempts to improve the osteo-
genic response of human MSC to BMP-2 and/or Dex
by culturing these cells on pure 45S5 bioactive glass
also did not have much success.
35 In this study, cul-
turing human MSC on the PLGA/A2-33 composite
sheets signiﬁcantly increased ALP/cell levels compared
to standard TCP. A similar tendency was observed for
PLGA/S2-33 composites. PLGA/A2-21 sheets also
enhanced BMP-2 mRNA expression of hMSC.
Furthermore, all the PLGA/S2 composites studied
enhanced cell-mediated calciﬁcation of extracellular
matrix (ECM) in either BMP-2 or Dex-mediated
osteogenic conditions. We compared Alizarin Red S
staining of composites in parallel cultures with and
without cells. Increased Alizarin Red S staining was
apparent for PLGA/S2 composite sheets that were
used as growth surfaces for bone marrow-derived
human MSC, regardless of cell treatments. Similar
data were obtained for PLGA/A2-12 composites, but
high staining intensity of composites containing higher
proportion of A2 S-BG in cell-free conditions did not
allow us to quantify the effect. In contrast, pure PLGA
did not support cell-mediated calciﬁcation of ECM in
either BMP-2 or Dex-enriched osteogenic medium
despite some ability of these cells to calcify ECM
with Dex on TCP (data not shown). Since PLGA/S2
composites showed moderate surface activity and/or
bioactivity in cell-free solutions, we suggest these
composite features may be a key to promotion of the
BMP-mediated osteogenic response of cells in vitro.
The potential for the presently studied composite
materials to be used as a bone graft substitute or tissue
engineering scaﬀold is further supported by our 3D
culture studies, despite they were done with another
cell population of known osteoblastic properties (i.e.,
MG-63 cell line) (Fig. 9). Cell distributions were
comparable within all studied constructs and compa-
rable numbers of live cells were detected after 2-week
MG-63 culture in all studied 3D scaffolds. However,
MG-63 cells cultured in 3D PLGA–BG composites
produced signiﬁcantly higher levels of collagen and
calcium suggesting osteoinductive properties of com-
posite scaffolds.
CONCLUSIONS
Our present studies have shown that it is possible
to produce a wide variety of bioactive composite
materials made of poly(L-lactide-co-glycolide) and sol–
gel derived bioactive glass. These composites differ
in mechanical performance, wettability, degradation
kinetics, bioactivity, and biological properties depend-
ing on the content and composition of bioactive glass.
The composites made of PLGA and silica-rich S2 bio-
active glass exhibit: (i) similar wettability as pure
PLGA, (ii) slow degradation kinetics, manifested by
neutral pH and stable conductivity values of the
incubation medium, (iii) good biological properties
manifested by enhanced human bone marrow cell
proliferation and osteoinductive properties in both 2D
and 3D culture systems. The composites made of
PLGA and calcium-rich A2 bioactive glass exhibit: (i)
high bioactivity manifested by crystallization of
hydroxyapatite and (ii) ability to promote both osteo-
blast and osteoclast formation. Thus, the composites
made of PLGA and sol–gel derived bioactive glasses
should ﬁnd wide applications where a mechanically
strong osteoinductive material is required for bone
tissue engineering and bone tissue regeneration.
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